Correlation Between Indaptus Therapeutics and Senti Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Senti Biosciences, you can compare the effects of market volatilities on Indaptus Therapeutics and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Senti Biosciences.

Diversification Opportunities for Indaptus Therapeutics and Senti Biosciences

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Indaptus and Senti is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Senti Biosciences go up and down completely randomly.

Pair Corralation between Indaptus Therapeutics and Senti Biosciences

Given the investment horizon of 90 days Indaptus Therapeutics is expected to under-perform the Senti Biosciences. In addition to that, Indaptus Therapeutics is 1.64 times more volatile than Senti Biosciences. It trades about -0.05 of its total potential returns per unit of risk. Senti Biosciences is currently generating about -0.05 per unit of volatility. If you would invest  263.00  in Senti Biosciences on August 31, 2024 and sell it today you would lose (49.00) from holding Senti Biosciences or give up 18.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Indaptus Therapeutics  vs.  Senti Biosciences

 Performance 
       Timeline  
Indaptus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Indaptus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Senti Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Senti Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Indaptus Therapeutics and Senti Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Indaptus Therapeutics and Senti Biosciences

The main advantage of trading using opposite Indaptus Therapeutics and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.
The idea behind Indaptus Therapeutics and Senti Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing